Edition:
United Kingdom

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

1.62USD
14 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.62
Open
$1.61
Day's High
$1.67
Day's Low
$1.58
Volume
15,991
Avg. Vol
63,705
52-wk High
$2.43
52-wk Low
$0.83

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Sep 0.00 -0.299
Jun 0.00 -0.195
FY 2018 Mar '18 0.00 -0.191
Dec 0.00 -0.250
Sep 0.00 -0.531
Jun 0.00 -0.278
FY 2017 Mar '17 0.00 -0.325
Dec 1.25 -0.343
Sep 0.00 -0.416
Jun 0.00 -0.514
FY 2016 Mar '16 0.00 -4.445
Dec 0.00 -1.952
Sep 0.00 -5.263
Jun 0.00 -19.233
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 1 0.00 0.00 0.00 --
Quarter Ending Sep-19 1 0.00 0.00 0.00 --
Year Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Mar-20 2 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Mar-18 1 -0.28 -0.28 -0.28 --
Quarter Ending Jun-19 1 -0.13 -0.13 -0.13 --
Year Ending Mar-18 2 -1.58 -1.08 -2.08 --
Year Ending Mar-19 1 -1.10 -1.10 -1.10 --
Year Ending Mar-20 2 -1.01 -0.54 -1.48 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.13 34.39
P/E High - Last 5 Yrs. -- 40.59 46.24
P/E Low - Last 5 Yrs. -- 23.99 24.59
Beta -0.57 0.91 0.91
Price to Sales (TTM) 13.68 4.00 6.22
Price to Book (MRQ) -- 5.02 5.20
Price to Tangible Book (MRQ) -- 5.76 6.74
Price to Cash Flow (TTM) -- 23.20 24.17
% Owned Institutions 18.15 0.95 1.78

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.44
Dividend Yield - 5 Year Avg -- 1.56 1.46
Dividend 5 Year Growth Rate -- 4.21 4.94
Payout Ratio(TTM) -- 45.68 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.33 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 4.80 6.50
Sales - 5 Yr. Growth Rate -1.41 10.00 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago 45.84 17.26 23.09
EPS (TTM) vs TTM 1 Yr. Ago 88.82 -- --
EPS - 5 Yr. Growth Rate -- 9.88 10.49
Capital Spending - 5 Yr. Growth Rate 49.14 15.23 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.28
Current Ratio (MRQ) 2.12 3.02 3.10
LT Debt to Equity (MRQ) -- 8.89 11.49
Total Debt to Equity (MRQ) -- 12.69 16.03
Interest Coverage (TTM) -5,804.00 35.18 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.41 54.44
Gross Margin - 5 Yr. Avg. -- 51.86 52.36
EBITD Margin (TTM) -838.44 -- --
EBITD - 5 Yr. Avg -3,202.01 18.41 13.16
Operating Margin (TTM) -843.66 14.42 6.07
Operating Margin - 5 Yr. Avg. -5,471.17 14.55 8.47
Pre-Tax Margin (TTM) -844.10 14.96 7.02
Pre-Tax Margin - 5 Yr. Avg. -6,012.32 14.97 8.71
Net Profit Margin (TTM) -844.30 11.16 3.12
Net Profit Margin - 5 Yr. Avg. -6,013.25 11.23 4.91
Effective Tax Rate (TTM) -- 23.45 23.26
Effective Tax Rate - 5 Yr. Avg. -- 23.65 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 997,011,333 873,051,409
Net Income/Employee (TTM) -- 118,232,370 103,483,755
Receivable Turnover (TTM) -- 5.82 5.80
Inventory Turnover (TTM) -- 2.68 3.56
Asset Turnover (TTM) 0.22 0.99 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -188.55 11.98 11.45
Return on Assets - 5 Yr. Avg. -1,968.05 13.28 12.50
Return on Investment (TTM) -245.77 15.55 14.96
Return on Investment - 5 Yr. Avg. -- 17.28 16.23
Return on Equity (TTM) -415.24 16.92 16.52
Return on Equity - 5 Yr. Avg. -- 18.21 17.37
  1 Year 3 Year 5 Year
Sales % -- -- -1.41
EPS (TTM) % 94.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for VistaGen Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.64 -6.96 23 20
13 Week -12.15 -16.43 25 34
26 Week -21.67 -27.63 20 28
52 Week -63.30 -68.90 6 12
YTD -57.37 -62.56 4 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.56%
# of Holders: 19
Total Shares Held: 3,591,580
3 Mo. Net Change: 247,996
# New Positions: 2
# Closed Positions: 7
# Increased Positions: 5
# Reduced Positions: 9
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.